Ira Glick is a Psychiatry physician. OpenAlex indexes 11 publications with 1,660 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-498-5710Registry record last updated 8 Jul 2007.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lundbeck LLCProgram year20241 payment
- Alkermes, Inc.Program year20231 payment
- Neurocrine Biosciences, Inc.Program year20223 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Atypical Antipsychotic82.4%Clozapine48%Risperidone30%Quetiapine Fumarate21%Part D<11 patientsTricyclic Antidepressant17.6%Imipramine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2005–2007 per NIH RePORTER. The latest:
- EFFICACY AND METABOLIC EFFECTS OF ARIPIPRAZOLE IN SCHIZOPHRENIA
Stanford University
FY2007$1,755M01RR000070 - SCHIZOPHRENIA AND WEIGHT GAIN ASSOCIATED WITH ATYPICAL ANTIPSYCHOTIC MEDICATIONS
Stanford University
FY2006$41,809M01RR000070 - SCHIZOPHRENIA AND WEIGHT GAIN ASSOCIATED WITH ATYPICAL ANTIPSYCHOTIC MEDICATIONS
Stanford University
FY2005$6,348M01RR000070
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”